- Home
- CGNT vs OABI Comparison
CGNT vs OABI Comparison
Compare CGNT & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGNT
- OABI
- Stock Information
- Founded
- CGNT 2020
- OABI 2012
- Country
- CGNT Israel
- OABI United States
- Employees
- CGNT N/A
- OABI N/A
- Industry
- CGNT Computer Software: Prepackaged Software
- OABI Biotechnology: Pharmaceutical Preparations
- Sector
- CGNT Technology
- OABI Health Care
- Exchange
- CGNT Nasdaq
- OABI Nasdaq
- Market Cap
- CGNT 465.2M
- OABI 459.1M
- IPO Year
- CGNT N/A
- OABI N/A
- Fundamental
- Price
- CGNT $6.92
- OABI $3.88
- Analyst Decision
- CGNT Hold
- OABI Strong Buy
- Analyst Count
- CGNT 3
- OABI 4
- Target Price
- CGNT $8.25
- OABI $9.00
- AVG Volume (30 Days)
- CGNT 223.2K
- OABI 453.1K
- Earning Date
- CGNT 12-11-2024
- OABI 11-12-2024
- Dividend Yield
- CGNT N/A
- OABI N/A
- EPS Growth
- CGNT N/A
- OABI N/A
- EPS
- CGNT N/A
- OABI N/A
- Revenue
- CGNT $330,212,000.00
- OABI $20,409,000.00
- Revenue This Year
- CGNT $12.89
- OABI N/A
- Revenue Next Year
- CGNT $6.94
- OABI $71.78
- P/E Ratio
- CGNT N/A
- OABI N/A
- Revenue Growth
- CGNT 12.00
- OABI N/A
- 52 Week Low
- CGNT $4.28
- OABI $3.56
- 52 Week High
- CGNT $8.70
- OABI $6.72
- Technical
- Relative Strength Index (RSI)
- CGNT 50.94
- OABI 39.08
- Support Level
- CGNT $6.38
- OABI $3.81
- Resistance Level
- CGNT $7.74
- OABI $4.19
- Average True Range (ATR)
- CGNT 0.24
- OABI 0.22
- MACD
- CGNT 0.05
- OABI -0.03
- Stochastic Oscillator
- CGNT 39.71
- OABI 6.60
About CGNT Cognyte Software Ltd.
Cognyte Software Ltd provides security analytics software that empowers governments and enterprises with Actionable Intelligence. Its interface software is designed to help customers accelerate and improve the effectiveness of investigations and decision-making.
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.